---
annotations:
- type: Pathway Ontology
  value: disease pathway
- type: Disease Ontology
  value: fatty liver disease
authors:
- Marvin M2
- Egonw
- Eweitz
description: Adverse outcome pathway for steatosis, originating from the AOPXplorer
  app for Cytoscape (http://apps.cytoscape.org/apps/aopxplorer).
last-edited: 2021-05-07
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4011
- /instance/WP4011
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4011.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Adverse outcome pathway for steatosis, originating from the AOPXplorer
    app for Cytoscape (http://apps.cytoscape.org/apps/aopxplorer).
  keywords:
  - AKT2
  - PRKCI
  - FASN
  - HSD17B4
  - Cytosolic fatty acids
  - SREBF1
  - TTI1
  - NR0B2
  - MTOR
  - RICTOR
  - Fatty Acid Beta Oxidation
  - NFE2
  - NR5A2
  - PPARG
  - FABP1
  - NR1H3
  - AKT1
  - TELO2
  - NR1H4
  - NR1H2
  - Insulin
  - DEPTOR
  - Lipogenesis
  - AKT1S1
  - PPARA
  - SCD
  - MLST8
  - RPTOR
  - MAPKAP1
  - PI3K
  - INSR
  license: CC0
  name: Steatosis adverse outcome pathway
seo: CreativeWork
title: Steatosis adverse outcome pathway
wpid: WP4011
---